Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 13 | 2026 | 341 | 2.810 |
Why?
|
| Calcium | 13 | 2026 | 370 | 2.760 |
Why?
|
| Muscular Diseases | 3 | 2026 | 17 | 1.940 |
Why?
|
| Malignant Hyperthermia | 5 | 2023 | 18 | 1.840 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 6 | 2026 | 141 | 1.350 |
Why?
|
| Doxorubicin | 1 | 2026 | 60 | 0.940 |
Why?
|
| Oxidative Stress | 1 | 2026 | 83 | 0.940 |
Why?
|
| Halothane | 3 | 2023 | 11 | 0.810 |
Why?
|
| Caffeine | 3 | 2023 | 54 | 0.800 |
Why?
|
| Sarcoplasmic Reticulum | 7 | 2026 | 164 | 0.790 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 148 | 0.770 |
Why?
|
| Muscle Contraction | 2 | 2023 | 68 | 0.750 |
Why?
|
| Calcium Signaling | 6 | 2026 | 120 | 0.740 |
Why?
|
| Muscle Fibers, Skeletal | 5 | 2025 | 45 | 0.670 |
Why?
|
| Animals | 15 | 2026 | 3270 | 0.610 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 34 | 0.480 |
Why?
|
| Mice | 11 | 2026 | 1238 | 0.460 |
Why?
|
| Hyperglycemia | 3 | 2025 | 32 | 0.410 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 55 | 0.380 |
Why?
|
| Calsequestrin | 6 | 2017 | 34 | 0.370 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 85 | 0.360 |
Why?
|
| Action Potentials | 2 | 2026 | 83 | 0.260 |
Why?
|
| Glycogen | 2 | 2024 | 13 | 0.250 |
Why?
|
| Blood Glucose | 2 | 2025 | 103 | 0.250 |
Why?
|
| Muscle Fatigue | 1 | 2026 | 11 | 0.250 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2026 | 20 | 0.240 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 102 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 363 | 0.220 |
Why?
|
| Humans | 9 | 2025 | 22912 | 0.210 |
Why?
|
| Muscle Proteins | 2 | 2022 | 25 | 0.210 |
Why?
|
| Glucose | 2 | 2023 | 45 | 0.210 |
Why?
|
| Calcium Channels, L-Type | 2 | 2022 | 52 | 0.200 |
Why?
|
| Age Factors | 1 | 2025 | 637 | 0.200 |
Why?
|
| Mutation | 3 | 2020 | 329 | 0.190 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 8 | 0.190 |
Why?
|
| Anesthetics, Inhalation | 2 | 2020 | 12 | 0.180 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2022 | 17 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 43 | 0.180 |
Why?
|
| Phenotype | 2 | 2020 | 260 | 0.180 |
Why?
|
| Cells, Cultured | 3 | 2018 | 462 | 0.170 |
Why?
|
| Male | 3 | 2026 | 12459 | 0.160 |
Why?
|
| Genotype | 1 | 2020 | 248 | 0.150 |
Why?
|
| Risk Factors | 1 | 2025 | 1971 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 106 | 0.150 |
Why?
|
| Myocardium | 2 | 2017 | 102 | 0.140 |
Why?
|
| Membrane Potentials | 3 | 2013 | 168 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 313 | 0.140 |
Why?
|
| Adult | 4 | 2025 | 6924 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2018 | 387 | 0.120 |
Why?
|
| Excitation Contraction Coupling | 1 | 2015 | 10 | 0.110 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 37 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 25 | 0.110 |
Why?
|
| Biosensing Techniques | 2 | 2011 | 11 | 0.110 |
Why?
|
| Cell Membrane Permeability | 2 | 2011 | 50 | 0.110 |
Why?
|
| Hypothermia | 1 | 2013 | 5 | 0.100 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 6 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 80 | 0.100 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2012 | 6 | 0.100 |
Why?
|
| Rabbits | 1 | 2013 | 166 | 0.100 |
Why?
|
| Rana pipiens | 1 | 2012 | 51 | 0.090 |
Why?
|
| Magnesium | 1 | 2012 | 36 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 173 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 302 | 0.080 |
Why?
|
| Algorithms | 1 | 2013 | 304 | 0.080 |
Why?
|
| Female | 3 | 2025 | 12939 | 0.080 |
Why?
|
| Fasting | 1 | 2025 | 22 | 0.060 |
Why?
|
| Biopsy | 1 | 2025 | 188 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2024 | 60 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 23 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 387 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 11 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 19 | 0.050 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 12 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 37 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 69 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2022 | 20 | 0.050 |
Why?
|
| Cytosol | 2 | 2012 | 41 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2023 | 140 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2011 | 85 | 0.040 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 3 | 0.040 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 3 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 3 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 130 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 592 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2017 | 107 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 89 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 262 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 23 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 9 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 40 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 112 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2011 | 12 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 34 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 97 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 526 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 7442 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 7911 | 0.020 |
Why?
|